Producto añadido correctamente al carrito.

discount label
H-ISQAVHAAHAEINE-OH
Ver en 3D

Biosynth logo

H-ISQAVHAAHAEINE-OH

Ref. 3D-PP43051

1mg
294,00 €
10mg
351,00 €
100mg
594,00 €
Entrega estimada en Estados Unidos, el Viernes 27 de Diciembre de 2024

Información del producto

Nombre:
H-ISQAVHAAHAEINE-OH
Sinónimos:
  • NH2-Ile-Ser-Gln-Ala-Val-His-Ala-Ala-His-Ala-Glu-Ile-Asn-Glu-OH
Descripción:

Peptide H-ISQAVHAAHAEINE-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ISQAVHAAHAEINE-OH include the following: TACI-BLyS signaling via B-cell-dendritic cell cooperation is required for naive CD8+ T-cell priming in vivo Y Diaz-de-Durana, GT Mantchev, RJ Bram , A Franco - Blood, 2006 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/107/2/594/131472 Immunization with plasmid DNA encoding MHC class II binding peptide/CLIP-replaced invariant chain (Ii) induces specific helper T cells in vivo: the assessment of Ii T Nagata, T Higashi, T Aoshi, M Suzuki, M Uchijima - Vaccine, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X01003103 Naturally occurring human IgM antibody that binds B7-DC and potentiates T cell stimulation by dendritic cells S Radhakrishnan, LT Nguyen, B Ciric - The Journal of , 2003 - journals.aai.orghttps://journals.aai.org/jimmunol/article/170/4/1830/71057 Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. RG van der Most, A Sette , C Oseroff - (Baltimore, Md.: 1950 , 1996 - journals.aai.orghttps://journals.aai.org/jimmunol/article-abstract/157/12/5543/29689 Naturally Occurring Human IgM Antibody RA Kyle, M Rodriguez , LR Pease, SY Tseng, T Shin - J , 2003 - researchgate.nethttps://www.researchgate.net/profile/Haidong-Dong/publication/10912066_Naturally_Occurring_Human_IgM_Antibody_That_Binds_B7-DC_and_Potentiates_T_Cell_Stimulation_by_Dendritic_Cells/links/00463530155629b86e000000/Naturally-Occurring-Human-IgM-Antibody-That-Binds-B7-DC-and-Potentiates-T-Cell-Stimulation-by-Dendritic-Cells.pdf Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivo MF Del Guercio, J Alexander, RT Kubo, T Arrhenius - Vaccine, 1997 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X97001862 Lipopeptide particles as the immunologically active component of CTL inducing vaccines I Tsunoda , A Sette , RS Fujinami, C Oseroff, J Ruppert - Vaccine, 1999 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X98002503 Novel Chlamydia muridarum T cell antigens induce protective immunity against lung and genital tract infection in murine models H Yu, X Jiang, C Shen, KP Karunakaran - The Journal of , 2009 - journals.aai.orghttps://journals.aai.org/jimmunol/article/182/3/1602/83630 Interferon-γ ELISPOT Assay for the Quantitative Measurement of Antigen-Specific Murine CD8+ T-Cells GA Cole - Handbook of ELISPOT: Methods and Protocols, 2005 - Springerhttps://link.springer.com/protocol/10.1385/1-59259-903-6:191 Engineering protein for X-ray crystallography: The murine major histocompatibility complex class II molecule I-Ad CA Scott, K Christoper Garcia, EA Stura - Protein , 1998 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/pro.5560070222 Synthesis of pyridyl disulfide-functionalized nanoparticles for conjugating thiol-containing small molecules, peptides, and proteins AJ Van Der Vlies , CP O'Neil , U Hasegawa - Bioconjugate , 2010 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bc9004443 An ingenious design for peptide vaccines A Yano, A Onozuka, Y Asahi-Ozaki, S Imai, N Hanada - Vaccine, 2005 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X05000344 RGD motif enhances immunogenicity and adjuvanicity of peptide antigens following intranasal immunization A Yano, A Onozuka, K Matin , S Imai, N Hanada - Vaccine, 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X03005619 Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. A Vitiello, G Ishioka, HM Grey, R Rose - The Journal of , 1995 - Am Soc Clin Investighttps://www.jci.org/articles/view/117662

Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:

Propiedades químicas

MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:

Información de peligrosidad

Número UN:
Cantidad exceptuada (EQ):
Clase:
Frases H:
Frases P:
Prohibido volar:
Información de peligrosidad:
Grupo de empaquetado:
Cantidad limitada (LQ):

Consulta técnica sobre: 3D-PP43051 H-ISQAVHAAHAEINE-OH

Use el carrito para solicitar presupuestos o pedidos

Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.

* Campos obligatorios
¡Bienvenido a CymitQuimica!Utilizamos cookies para mejorar su visita. No incluimos publicidad.

Consulte nuestra Política de Cookies para obtener más información o ajuste sus preferencias en "Configurar".